Event Type: Earnings Call with analyst(s)/institutional investor(s)
Financial Period Discussed: Unaudited Financial Results for the quarter and half year ended September 30, 2026 (Q2 FY27)
Event Date: Wednesday, November 04, 2026
Recording Availability: Audio recording has been made available on the Company's website at https://anthembio.com/financial-information/
Regulatory Compliance: Disclosure made pursuant to Regulation 30 and Regulation 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Additional Notes Section
Management Participants: Not specified in this disclosure
UPSI Statement: No explicit statement regarding unpublished price sensitive information was included
Financial Data: No actual financial figures or results were disclosed in this announcement
Attachments: No attachments were mentioned in this specific disclosure
